<p>PATZ1 fusion neuroepithelial tumors (NET) are beginning to be recognized as a distinct molecular class of neoplasms that most often occur in children and young adults. These tumors are polyphenotypic, show diverse morphologic features, may be low- or high-grade, and tend to have an intermediate prognosis. We present a rare case of a high-grade NET harboring an EWSR1::PATZ1 fusion, identified through DNA methylation profiling and validated by gene expression analysis. The case involved a 21-year-old female presenting with headaches and seizures. The tumor was supratentorial in close relation to the lateral ventricle, preferentially located in the parietal lobe. Morphologically it showed predominant sarcomatous morphology with high mitotic activity and a high Ki-67 index leading to its initial diagnosis of gliosarcoma. Awareness of the emerging entity of PATZ1 fusion NET is important not only for accurate diagnostic and prognostic purposes but also for predicting response to therapy.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Unveiling a genetic rarity: intracranial sarcomatous tumor with EWSR1::PATZ1 fusion—a case report and review of the literature

  • Swati Mahajan,
  • Jyotsna Singh,
  • Ashwinee Kumar,
  • Shrinidhi Vasant,
  • Amandeep Kumar,
  • Ajay Garg,
  • M. C. Sharma,
  • Vaishali Suri

摘要

PATZ1 fusion neuroepithelial tumors (NET) are beginning to be recognized as a distinct molecular class of neoplasms that most often occur in children and young adults. These tumors are polyphenotypic, show diverse morphologic features, may be low- or high-grade, and tend to have an intermediate prognosis. We present a rare case of a high-grade NET harboring an EWSR1::PATZ1 fusion, identified through DNA methylation profiling and validated by gene expression analysis. The case involved a 21-year-old female presenting with headaches and seizures. The tumor was supratentorial in close relation to the lateral ventricle, preferentially located in the parietal lobe. Morphologically it showed predominant sarcomatous morphology with high mitotic activity and a high Ki-67 index leading to its initial diagnosis of gliosarcoma. Awareness of the emerging entity of PATZ1 fusion NET is important not only for accurate diagnostic and prognostic purposes but also for predicting response to therapy.